Smith & Nephew, Inc. (NYSE: SNN), Saint Petersburg, FL – FDA Inspections
Inspection records and compliance data for Smith & Nephew, Inc. in Saint Petersburg, Florida. 4 FDA inspections on record (1 OAI), last inspected January 13, 2015. Publicly traded as NYSE: SNN.
This profile covers Smith & Nephew, Inc. based in Saint Petersburg, Florida, United States.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 1
- VAI
- 1
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected September 4, 2009. Last inspected January 13, 2015.
Most cited issue areas
- Lack of or inadequate procedures2 inspections
- Design changes - Lack of or Inadequate Procedures1 inspection
- Design Validation - Risk analysis not performed/inadequate1 inspection
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| January 13, 2015 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 907062 |
| November 26, 2013 | OAI | Medical Devices & Rad Health · Compliance: Devices | 858923 |
| August 31, 2011 | VAI | Medical Devices & Rad Health · Compliance: Devices | 743018 |
| September 4, 2009 | NAI | Human Drugs · Drug Quality Assurance | 610762 |
No Form 483s, Warning Letters or EIRs on record.
Companies with similar regulatory profiles, compliance history, and operations.
Name
Smith & Nephew, Inc.
Stock ticker
SNN
Exchange
NYSE
Share price
$32.03
Market cap
$13.4B
Price as of
November 6, 2026
FEI Number
3006760724
Address
970 Lake Carillon Dr Ste 110, Saint Petersburg, Florida 33716, United States
Country
United States
ID: e0dd5fec-72a6-4e0a-9b58-e213b7e0c570